Free Trial
→ Sorry about the swear word (From Manward Press) (Ad)
OTCMKTS:BIOQ

Bioqual 1/21/2025 Earnings Report

Bioqual logo
$44.25 0.00 (0.00%)
As of 06/17/2025
ProfileEarnings History

Bioqual EPS Results

Actual EPS
-$1.36
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Bioqual Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Bioqual Announcement Details

Quarter
Date
1/21/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Bioqual Earnings Headlines

BIOQUAL Announces the retirement of Dr. Mark G. Lewis as President and CEO of the company
April 30, 2025 | businesswire.com
BIOQUAL Announces Retirement of Mike O'Flaherty From Board
April 24, 2025 | businesswire.com
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
June 18, 2025 | Porter & Company (Ad)
BIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2025
April 11, 2025 | finance.yahoo.com
BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2025
January 21, 2025 | finance.yahoo.com
BIOQUAL Announces Changes to Board of Directors
January 14, 2025 | finance.yahoo.com
See More Bioqual Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Bioqual? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bioqual and other key companies, straight to your email.

About Bioqual

Bioqual (OTCMKTS:BIOQ), Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.

View Bioqual Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles